IJU this issue

This issue contains one Guideline, Review Article, 12 Original Articles and two Urological Notes. The Committee for the Development of Guidelines Infection Control in Field, including Urinary Tract Management Japanese Association, together with its systematic review team external reviewers, have prepared a set practice guidelines. Takahashi et al. (Sapporo, Japan) created an abridged version those guidelines as (revised second edition). revised edition, along topics from first includes information on hepatitis B virus reactivation urinary catheter management home care, which consists 53 clinical questions. It also covers new sections comprising details not only urologists, but healthcare professionals involved tract management. Although narrow band imaging (NBI) has been previously shown to improve detection lesions over white light, it is unclear that NBI reduces recurrence rates patients undergoing transurethral resection bladder tumor (TURBT) compared conventional light TURBT. In this Gravestock (Newcastle, UK) assessed effect NBI-guided TURBT non-muscle-invasive cancer. According diagram outlining study selection based Preferred Reporting Items Systematic Reviews Meta-analyses, three randomized controlled trials were included article. contrast previous reviews, no statistically significant result was obtained, although trend favor shown. Currently, benefit use during remains unclear, further well-designed are warranted. Two robot-assisted partial nephrectomy (RAPN) issue. Yokoyama (Tokyo, carried out nationwide retrospective evaluate trends safety RAPN initial 2-year period after government approval type procedure April 2016. During period, number RAPNs institutions surgery steadily increased, resulting 3722 cases receiving surgery. found surgical outcomes practically equivalent between lower- higher-volume institutions. conclusion, associated acceptable profile good outcomes, regardless institutional caseloads. Based theory renal ischemia, warm particular, contributes function loss, there debate maximum tolerable ischemic time. Ishiyama multi-institutional association time postoperative function. 1131 patients, classified into shorter (<30 min; n = 1038) longer (≥30 92) groups required. when matched baseline characteristics, ≥30 min, required large more complex tumors, did inferior short- mid-/long-term RAPN. Pembrolizumab overall survival (OS) advanced or metastatic urothelial carcinoma resistant platinum-based chemotherapy. optimal cycles chemotherapy, however, yet determined considering efficacy subsequent pembrolizumab OS. Kato (Osaka, multicenter, determine impact objective response chemotherapy authors best independent prognostic factors OS, indicating therapeutic can be expected irrespective None declared.